INTRODUCTION
Relatively little is known about the regulation of CXCL1/KC expression or its role in inflammation. However, the prototype Toll-like receptor (TLR) 4 agonist, Gram-negative lipopolysaccharide (LPS), is a very potent inducer of CXCL1/KC in vitro and in vivo. [3] [4] [5] For example, CXCL1/KC steady-state mRNA is increased 60-fold over baseline levels by 1 h in murine macrophage cultures and remains elevated for 48 h; similarly, hepatic CXCL1/KC gene expression was up-regulated within an hour of LPS administration to mice. In contrast to many LPS-inducible pro-inflammatory genes, induction of CXCL1/KC is blunted by the Th1 cytokine, IFN-γ. 3 In macrophages rendered 'endotoxin tolerant' by prior exposure to LPS, CXCL1/KC is poorly inducible. 4 In a mouse model of polymicrobial sepsis induced by cecal ligation and sepsis, CXCL1/KC mRNA was strongly and rapidly induced in the livers and lungs and associated with increased neutrophil infiltration into these organs. 6 Despite the fact that CXCL1/KC has been observed to be strongly up-regulated in a variety of in vitro and in vivo systems, its role in the induction of a protective versus pathological response remains controversial. For example, overexpression of CXCL1/KC in the lungs of transgenic mice resulted in significant neutrophil infiltration in the absence of tissue injury; however, these infiltrating neutrophils still contained their cytoplasmic granules, indicating that they had not undergone degranulation. 7, 8 Transient overexpression of CXCL1/KC in the lungs of mice resulted in a significant level of survival and reduction of fungal burden in response to challenge with invasive aspergillosis 9, 10 as well as enhanced resistance to Klebsiella pneumoniae infection. 11 On the other hand, several studies provided a strong association for a role of CXCL1/KC in disease. Boisevert et al. 12 mated CXCL1/KC -/mice with atherosclerosis-prone LDLR -/mice and observed a significant protective effect against development of atherosclerosis when compared to CXCL1/KC-competent control mice. In a model of hemolytic uremic syndrome (HUS) induced by co-administration of LPS and shiga toxin produced by Escherichia coli, Obrig and colleagues 13 demonstrated that the pathology, including neutrophil infiltration into the kidneys that is characteristic of HUS, was inhibited by co-administration of antibodies against CXCL1/KC and CXCL2/MIP-2. 14 In this study, we determined the role of CXCL1/KC in the intestinal response to inflammation using mice with a targeted mutation in CXCL1/KC. The findings presented herein demonstrate that mice deficient in CXCL1/KC exhibit a much more profound colitis in response to dextran sodium sulfate (DSS), supporting a protective role of CXCL1/KC-mediated recruitment of neutrophils in this model.
MATERIALS AND METHODS

Mice
Mice with a targeted mutation in CXCL1/KC were derived as described by Boisvert et al. 12 and backcrossed 14 generations to C57BL/6J mice (Jackson Laboratories; Bar Harbor, ME, USA). C57BL/6J mice were used as wild-type controls. CXCL1/KC -/mice were maintained in a specific pathogen-free (SPF) barrier facility at UMB and were fed sterile food and hyperchlorinated water with autoclaved bedding. All animal experiments were carried out within our institution's AAALAC-accredited program following Institutional Animal Care and Use Committee (IACUC) approval.
DSS model of colitis
DSS-induced colitis was induced exactly as described by Fukata et al. 15 Briefly, DSS with a molecular weight of 36-50 kDa (MP Biomedicals, Lot No. 8825H) was dissolved in water at 2.5% (w/v) and the bottles changed daily. It is important to note that DSS lots differ greatly in their ability to induce experimental colitis and the dosage used may have to be determined empirically. While administration of 5% DSS led to occasional deaths in C57BL/6J wild-type control mice, administration of 2.5% DSS to wild-type mice resulted in little or no signs of disease. A final concentration of 2.5% DSS was chosen because it clearly discriminated between the wild-type and CXCL1/KC -/mice (see below).
To quantify the extent of mucosal damage, the entire length of the small intestine and colon was removed en bloc. Sections of small intestine were taken at 5 (upper jejunum; I-1), 15 (jejunum; I-2), and 25 (ileum; I-3) cm from the pylorus. The cecum was removed and sections were taken from the mid-proximal (PC) and mid-distal (DC) colon. Tissue was fixed in 4% paraformaldehyde, paraffin embedded, sectioned (5 µm), and stained with Wright-Giemsa or hematoxylin and eosin (H&E). Assessment of microscopic inflammation was performed by two investigators who were unaware of the treatment groups. The histological score was a combined score of acute inflammatory cell infiltrate (neutrophils, 0-4), chronic inflammatory cell infiltrate (mononuclear cells, 0-3), and crypt damage (0-4) ( Table 1) . Specifically, the crypt damage was scored as follows: score of 0 was given to an intact crypt, 1 = loss of the basal one-third of crypt, 2 = loss of basal two-thirds of crypt, 3 = entire loss of crypt, and 4 = loss of crypt and surface epithelium. [15] [16] [17] The number of neutrophils was counted in Giemsa-stained sections of I-3, PC, and DC for each mouse in 10 consecutive fields (x1000) that had well-oriented architecture.
Microsnapwell assay of transepithelial electrical resistance (TEER)
To determine if mice deficient in CXCL1/KC possess an inherent defect in intestinal permeability, intestinal transepithelial electrical resistance (TEER) and changes in TEER in mouse small intestine were measured using the microsnapwell system. 18 Briefly, sections of small intestine from wild-type or mice deficient in CXCL1/KC were stripped of smooth muscle and mounted in microsnapwells and TEER was measured every 30 min for 90 min.
RESULTS
CXCL1/KC -/mice respond to DSS with significant weight loss
Wild-type and CXCL1/KC -/mice were provided water or 2.5% DSS in water ad libitum and weighed over an 8-day period. Higher concentrations of DSS caused significant mortality in the CXCL1/KC -/mice. Figure 1 shows that over this time period, the wild-type mice did not lose weight and showed minimal signs of illness, while the CXCL1/KC -/mice lost 18% of their starting weight (and were 31% below the weight of DSS-treated wild-type mice at day 8), exhibited bloody stools within 5 days of DSS administration, and many appeared to be moribund by day 7-8. It is important to note that both the wild-type and CXCL1/KC -/mice were housed in an extremely clean barrier facility that is free of adventitious pathogens. This, coupled with the observation that different lots of DSS exhibit variability in their capacity to induce inflammation, as well as strain differences in susceptibility to DSS, may account for the fact that the wild-type mice used in our study failed to show any overt signs of inflammation or injury, in contrast to other similar studies carried out under apparently similar conditions. 15, 19 
Microscopic damage in DSS-treated wild-type and CXCL1/KC -/mice
Representative photomicrographs from control (water only) and DSS-treated wild-type (C57BL/6) and CXCL1/KC -/mice are shown in Figure 2A ,B, respectively. The small intestine morphology was essentially unaltered by DSS treatment in wild-type mice at this concentration of DSS. Similarly, DSS did not cause significant injury to the colonic mucosa in wild-type mice, but did induce a marked smooth muscle hypertrophy in the muscularis externa of this region ( Fig. 2A , PC and DC). There was no difference in the microscopic appearance of the small intestine or colon in vehicle-treated wild-type and CXCL1/KC -/mice, although there was some suggestion of hyperplasia of mucus in the colon, but not in the intestine of the CXCL1/KC -/mice. In contrast to wild-type mice, however, DSS treatment induced significant changes in the GI tract of CXCL1/KC -/mice ( Fig. 2B ). Damage was not evident in the duodenum or jejunum (I-1, I-2), but the ileum (I-3) showed marked sloughing of surface epithelial cells extending along the length of the villi. DSS induced significant damage in the colonic mucosa of CXCL1/KC -/mice. The proximal colon (PC) featured epithelial sloughing, inflammatory infiltrate in the mucosa and submucosa as well as in the smooth muscle. The distal colon (DC) in DSS-treated CXCL1/KC -/mice was characterized by marked mucosal hypertrophy and mucus hyperplasia with alternating areas of moderate-to-severe damage including loss of epithelial, goblet cells, and crypts. There was also marked inflammatory infiltrate containing primarily mononuclear inflammatory cells ( Fig. 2C ) as well as lymphoid aggregates. The mean microscopic injury scores that were read in a blinded fashion showed that the response to DSS was increased slightly in wild-type mice, but was exaggerated greatly in the CXCL1/KC -/mice with significant injury in the distal small intestine and colon ( Fig. 2D ). Examination of sections under high power revealed modest neutrophil infiltration in sections derived from DSS-treated wild-type mice, despite the fact that they exhibited little outward signs of illness (Fig. 3A,C) . Infiltration was primarily around crypts and was clustered, rather than uniform in distribution (Fig.  3A) . In contrast, neutrophils were not detected in most sections derived from DSS-treated CXCL1/KC -/mice despite significant mucosal injury and marked mononuclear inflammatory infiltrate (Fig. 3B,C) .
CXCL1/KC -/mice do not exhibit basal intestinal leak
It has been reported previously that mice with a targeted mutation in MyD88, a key adapter molecule for TLR/IL-1R-mediated signaling, exhibited increased susceptibil- ity to DSS-induced damage, similar to the response of CXCL1/KC -/mice shown herein. 15, 19 Subsequently, we showed that MyD88 -/mice, but not TLR4 -/mice, exhibited 'leaky' intestines in the absence of exogenous stimulation as measured by decreased transepithelial electrical resistance (TEER) when compared to wildtype intestinal segments. 20 Therefore, we also compared CXCL1/KC -/intestinal segments to those of wild-type mice for basal TEER levels. In contrast to MyD88 -/mice, CXCL1/KC -/intestines were not 'leaky' basally (TEER measured at 90 min, CXCL1/KC -/-= 49.0 + 7.6 Ω.cm 2 (n = 3) versus wild-type = 40.3 + 4.1 Ω.cm 2 (n = 5), respectively; P > 0.05, Student's t-test). Thus, the increased sensitivity of CXCL1/KC -/mice to DSS-induced intestinal damage cannot be attributable to basal 'leakiness'.
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DISCUSSION
This report demonstrates that the failure to express a single chemokine, CXCL1/KC, results in a profoundly impaired intestinal response to exposure to DSS. These data point to CXCL1/KC as an important mediator of gut integrity in the DSS model of colitis. Previous reports demonstrated that TLR4 -/-, TLR2 -/-, and MyD88 -/mice exhibit a similar phenotype in response to DSS. 15, 19 Together, these findings support the concept that TLR activation and neutrophil recruitment have beneficial effects to the maintenance and restoration of mucosal homeostasis during inflammation.
There are a number of experimental models of inflammatory bowel disease (IBD) including both chemically induced (e.g. DSS, trinitrobenzene sulfonic acid) and mice with targeted gene deletions in specific cytokines. For example, mice with a targeted mutation in the gene that encodes IL-10, an anti-inflammatory cytokine, spontaneously develop colitis and have been used as a model for IBD. 21, 22 However, when such mice are reared under germ-free conditions, colitis fails to develop, 21 indicating the importance of gut flora to the induction of the colitis. TLR4 expression is normally low in intestinal epithelial cells, but can be induced by pro-inflammatory cytokines such as TNF-α and IFN-γ, 23 both of which are increased in the absence of IL-10. 24 Based on these and other observations, two groups independently postulated that TLR4 or TLR2 signaling through a MyD88-dependent signaling pathway, induced by the innate immune response to commensal bacteria, protects against the induction of chemically-induced colitis. 15, 19 Oral administration of DSS to mice is commonly used as a model of colon inflammation in which the epithelial barrier is disrupted, leaving the lamina propria exposed to gut bacteria. Mice lacking TLR2, TLR4, or the adapter molecule, MyD88, were significantly more susceptible to DSS- There is also an acute inflammatory infiltrate in the lumen (arrow). The right photomicrograph (x1000 Giemsa staining) shows typical inflammatory infiltrate in mucosa, featuring primarily lymphocytes (arrow) and macrophages (arrowhead). (D) Injury score for each section examined by two independent readers as described in Materials and Methods. Results represent the mean ± SEM for each treatment group. DSS-treated KC mice had significantly greater injury in I3 (P < 0.01), PC (P < 0.001) and DC (P < 0.001) when compared to DSS-treated wild-type mice. D induced colitis and exhibited a greatly reduced capacity for intestinal epithelial proliferation, indicating that TLR signaling in response to gut flora is important for maintenance of normal epithelial barrier function. 15, 19 Consistent with these findings, TLR4 -/and MyD88 -/mice exhibited bloody stools and rectal bleeding prior to DSS-treated wild-type mice, as well as bacterial translocation to the mesenteric lymph nodes that was not observed in wild-type mice. 15 The observation that mice deficient in MyD88 have a constitutively impaired barrier function, as evidenced by basally decreased TEER, 12 may contribute to the increased susceptibility to DSS in these mice. Collectively, these data suggest that TLR signaling in response to the presence of commensal bacteria after epithelial injury is required for re-establishment of gut integrity. It is interesting to note that mice with a targeted mutation in the vitamin D 3 receptor are also highly susceptible to DSS-induced colitis as well as to i.v. administration of LPS, and like their wild-type controls, pro-inflammatory cytokines, including CXCL1/KC, could be detected in colonic homogenates in mice treated with DSS. 25 However, whether vitamin D regulates TLR signaling pathways to maintain gut integrity is unknown.
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In humans, CXCL8 (IL-8) has two receptors, CXCR1 and CXCR2. In the mouse, however, CXCR2 appears to serve as the receptor for CXCL1/KC; CXCL1/KC was shown to be an ineffective ligand for mCXCR1 as measured by [ 35 S]-GTPγS exchange. 26 In a very recent report, however, Buanne et al. 27 showed that mice with a targeted mutation in CXCR2 exhibited ameliorated inflammation in a model of chronic experimental colitis induced by two consecutive cycles of 4% DSS (separated by 14 days of water only) as evidenced by lower clinical, histopathological and pathological scores in the CXCR2 -/mice from days 20-27 of treatment than observed in wild-type mice. It should be noted that, at the end of the first cycle of DSS treatment (day 6), the clinical, histological, and pathological scores of wildtype and CXCR2 -/mice receiving DSS were not signif- There was modest polymorphonuclear infiltrate in wild-type with little evidence of mucosal injury (see Fig. 2A -DC, DSS). In contrast, there were few neutrophils evident in CXCL1/KC -/mice (quantified in C; mean ± SEM; *P < 0.05), although the mice exhibited marked mucosal damage (see Fig. 2B -DC, DSS). The greater cellularity and mucus hyperplasia evident in the distal colon in Figure 2 is also present in these sections.
A B
C icantly different, in contrast to the findings presented herein. This suggests that, during the initial exposure to DSS, CXCR2 is less important in the 'acute' inflammatory response and, perhaps, CXCR1 substitutes as a lowaffinity receptor. Although one might postulate that an additional receptor for CXCL1/KC exists, there is currently no evidence for this possibility. It is also possible that the discrepancies observed in our study and that of Buanne et al. are attributable to the dose of DSS and strain differences in the mice used. The concentration of DSS used in the study by Buanne et al. 27 was considerably higher than that used herein. At 2.5% DSS, the CXCL1/KC -/mice were moribund at day 8, while control mice showed essentially no overt signs of illness (including no weight loss; Fig. 1 ) and only minimal histopathology (Fig. 2D) . Importantly, in our study (and those by Fukata et al. 15 and Rakoff-Nahoum et al. 19 ), the mice with targeted mutations were backcrossed onto a C57BL/6 background, while in the study by Buanne et al., 27 the mice were in a BALB/c background. Significant differences in inflammatory responses between these two inbred strains have been reported previously (e.g. in response to Leishmania infection 28 ) and might contribute to differences observed in the two studies. Lastly, differences in the exposure of mice to environmental pathogens may influence sensitivity to DSS: Jackson Laboratories houses both C57BL/6J and BALB/cJ mice with IL-10-deficient mice for 7 days 'to facilitate the transfer of enteric bacteria necessary to induce colitis by DSS. 29 Neutrophil infiltration into mucosal epithelia is a hallmark of IBD and accumulation within epithelial crypts and in the intestinal lumen is linked to clinical disease activity and epithelial injury (reviewed by Hanauer 30 ). In colonic mucosa of IBD patients, increased macrophagemediated generation of IL-8 and CXCL1/KC (Gro-α) was correlated positively with disease activity. 31 Despite the established contribution of neutrophils to active mucosal inflammation, as well as the correlation of neutrophil infiltration with severe inflammation in the chronic relapsing DSS colitis model. 27 there is a growing recognition that recruitment of neutrophils during inflammation also exerts beneficial effects. Hans et al. 32 found that neutrophil depletion of mice led to aggravation of DSS-induced colitis. Fukata et al. 15 reported that by 5 days after DSS, TLR4 -/and MyD88 -/mice exhibited essentially no neutrophil infiltration into the lamina propria or submucosa in contrast to wild-type mice, and this was correlated with decreased production of MIP-2 by lamina propria macrophages. Our data extend these observations, but suggest that a deficit of CXCL1/KC, rather than MIP-2 (another CXCR2 ligand), is likely to be primarily responsible for the lack of neutrophil infiltration observed by Fukata et al. 15 This observation is also consistent with the recent finding of Qualls et al. 33 that depletion of macrophages by intrarectal administration of chlodronate-encapsulated liposomes, but not control liposomes, to wild-type mice resulted in marked colitis in response to subsequent administration of DSS in the drinking water. The present study also demonstrates that the augmented inflammation in response to DSS in the CXCL1/KC-deficient mice is not linked to a constitutive defect in barrier function as mucosal resistance was similar to that in wild-type mice. Together, these data imply that the innate immune response to commensal flora through TLR2 and TLR4, MyD88mediated signaling, results in production of CXCL1/KC that recruits neutrophils in response to DSS. Thus, the data of Qualls et al., 33 coupled with our own, clearly suggest that recruitment of neutrophils by macrophagederived or macrophage-mediated production of CXCL1/KC is protective in this model.
CONCLUSIONS
These data are the first to demonstrate a protective role for endogenous CXCL1/KC in disease, extending earlier findings that lung-specific transgenic expression of CXCL1/KC in mice enhances resistance to fungal and K. pneumoniae infections. [9] [10] [11] Future studies to characterize the role of this potent neutrophil chemokine in protection or enhancement of other diseases will potentially lead to therapeutic approaches that target this important inflammatory molecule in diseases associated with colitis.
